Abstract:Abstract BACKGROUND As cancer survival rates improve, understanding and preventing the adverse off-target and long-term impacts of cancer treatments, including impacts on fertility, have become increasingly important. Cancer therapy-mediated damage to the ovary and depletion of the primordial follicle reserve are well characterised. However, our knowledge of the full extent of damage to the rest of the female reproductive tract, in particular the uterus, is limited. OBJECTIVE AND RATIONALE Improving our understanding of the off-target effects of cancer therapies on the entire female reproductive tract is a critical step towards developing truly effective strategies to protect the fertility of cancer survivors. The objective of this narrative review was to critically evaluate the available literature regarding the capacity for the uterus to sustain a healthy pregnancy following exposure to radiotherapy or chemotherapy. SEARCH METHODS The authors performed PubMed (Medline) searches using the following key words: uterus, cancer survivors, radiotherapy, chemotherapy, pregnancy outcome, fertility preservation, infertility. There were no limits placed on time of publication. OUTCOMES Overall, there were major limitations to the current available literature, meaning that interpretations should be taken with caution. Despite these drawbacks, data suggest that the uterus may sustain off-target damage, with the extent of damage dependent on the type of cancer treatment and patient age. Specifically, uterine growth is stunted and resistant to hormone replacement therapy in prepubertal girls receiving abdominal, pelvic or whole-body radiotherapy. In contrast, females treated with radiotherapy post-puberty can benefit from hormone replacement therapy, as demonstrated by increased uterine volume and function. No live births have been reported in women previously exposed to radiotherapy after transplantation of cryopreserved ovarian tissue, even when menstruation returns. However, this technique has proven to be a successful fertility preservation method for women previously treated with chemotherapy. Obstetricians commonly report that women who maintain sufficient ovarian function can achieve pregnancy naturally following radiotherapy, but they have thin and/or fibrotic myometrium at delivery, compromising safe delivery and subsequent pregnancy. Furthermore, women exposed to either radiotherapy or chemotherapy have a higher prevalence of preterm birth and low birth weight infants, even in those with normal ovarian function or when oocyte donation is utilised. The mechanisms of potential uterine damage are poorly understood. While the myometrium, vasculature and endometrial progenitor cells are possibly targets, further studies are clearly required and well-controlled animal models could provide the best avenue for these types of future investigations. WIDER IMPLICATIONS Female cancer survivors experience greater rates of early pregnancy loss and complications, suggesting that cancer therapy-induced damage to the uterus contributes to infertility. Despite clinical reports dating back to 1989, we highlight a surprising lack of detail in the literature regarding the precise nature and extent of off-target damage inflicted to the uterus in response to cancer therapies. Young women requiring cancer treatment, and the clinicians treating them, must be equipped with accurate information to aid informed decision-making regarding cancer treatment regimens as well as the development and use of effective fertility preservation measures. As the current literature on the impacts of cancer treatments is limited, we hope that our narrative review on this subject will stimulate more research in this important field.

Mechanisms and Risk Assessment of Cancer Treatment-Induced Female Fertility Impairment

An Update on Primary Ovarian Insufficiency

Molecular Mechanisms Determining Mammalian Oocyte Quality with the Treatment of Cancer Therapy

Do cancer therapies damage the uterus and compromise fertility?

Risk Assessment of Fertility in Cancer Patients

Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms

Fertility Issues in Cancer Survivorship

Chemotherapy drug combinations induced maternal ovarian damage and long-term effect on fetal reproductive system in mice

The Effect of Different Cancer Therapies on Clinical Outcomes of Assisted Reproductive Technology in Breast Cancer Patients

[Transposed Ovarian Function Conservation in Cervical Cancer Patients with Radiotherapy].

Fertility-sparing treatment in female genital cancer and breast cancer

Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients

[The Fertility-Associated Treatment of Young Breast Cancer Patients].

Effects of malignancies on fertility preservation outcomes and relevant cryobiological advances

Fertility Preservation in Young Female Cancer Patients

Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis

Chemotherapy induced oxidative stress in the ovary: drug-dependent mechanisms and potential interventions

Radiotherapy exposure directly damages the uterus and causes pregnancy loss

New perspectives of fertility sparing surgery in ovarian cancer treatment

Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review

Fertility optimization in women with cancer: from preservation to contraception